tiprankstipranks
Advertisement
Advertisement
Eli Lilly Advances Oral Pipeline With New LY4065967 Formulation Study
PremiumCompany AnnouncementsEli Lilly Advances Oral Pipeline With New LY4065967 Formulation Study
2d ago
Lilly’s LY4086940 Phase 1 Wrap‑Up: Reading the Signals for Obesity and Diabetes Investors
Premium
Company Announcements
Lilly’s LY4086940 Phase 1 Wrap‑Up: Reading the Signals for Obesity and Diabetes Investors
2d ago
Lilly’s Lepodisiran Liver Study Completion Signals Next Steps for a Key Pipeline Asset
Premium
Company Announcements
Lilly’s Lepodisiran Liver Study Completion Signals Next Steps for a Key Pipeline Asset
2d ago
OmniAb announces collaboration and license agreement with Eli Lilly
PremiumThe FlyOmniAb announces collaboration and license agreement with Eli Lilly
4d ago
Cboe data shows mixed options sentiment in Eli Lilly with shares up 0.46%
Premium
The Fly
Cboe data shows mixed options sentiment in Eli Lilly with shares up 0.46%
4d ago
Psychedelic: Definium’s LSD-based pill meets endpoints in GAD study
Premium
The Fly
Psychedelic: Definium’s LSD-based pill meets endpoints in GAD study
4d ago
PRIMECAP Management Co trims Eli Lilly stake by 50K
PremiumCompany AnnouncementsPRIMECAP Management Co trims Eli Lilly stake by 50K
6d ago
Clough Capital Partners boosts Eli Lilly stake by 21k shares
Premium
Company Announcements
Clough Capital Partners boosts Eli Lilly stake by 21k shares
6d ago
ARK Investment’s Cathie Wood boosts Eli Lilly stake 64,578 shares
Premium
Company Announcements
ARK Investment’s Cathie Wood boosts Eli Lilly stake 64,578 shares
6d ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100